(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of F2RL1 mRNA] CTD PMID:31150632 (6aR,11aS,11bR)-10-acetyl-11-hydroxy-7,7-dimethyl-2,6,6a,7,11a,11b-hexahydro-9H-pyrrolo[1',2':2,3]isoindolo[4,5,6-cd]indol-9-one multiple interactions ISO RGD:733704 6480464 cyclopiazonic acid inhibits the reaction [F2RL1 protein results in increased transport of Chlorides] CTD PMID:11804840 1,2-dimethylhydrazine decreases expression ISO RGD:1553673 6480464 1, 2-Dimethylhydrazine results in decreased expression of F2RL1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of F2RL1 mRNA CTD PMID:30723492 17beta-estradiol multiple interactions ISO RGD:733704 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of F2RL1 mRNA more ... CTD PMID:20660070 more ... 17beta-estradiol increases expression ISO RGD:733704 6480464 Estradiol results in increased expression of F2RL1 mRNA CTD PMID:31614463 17beta-estradiol decreases expression ISO RGD:733704 6480464 Estradiol results in decreased expression of F2RL1 mRNA CTD PMID:24758408 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:733704 6480464 2 more ... CTD PMID:36804509 2,2',5,5'-tetrachlorobiphenyl increases expression ISO RGD:733704 6480464 2 more ... CTD PMID:36804509 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733704 6480464 Tetrachlorodibenzodioxin results in decreased expression of F2RL1 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of F2RL1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553673 6480464 Tetrachlorodibenzodioxin affects the expression of F2RL1 mRNA CTD PMID:26377647 2-hydroxypropanoic acid increases expression ISO RGD:733704 6480464 Lactic Acid results in increased expression of F2RL1 mRNA CTD PMID:30851411 3',5'-cyclic AMP multiple interactions ISO RGD:733704 6480464 Cyclic AMP promotes the reaction [F2RL1 protein results in increased transport of Chlorides] CTD PMID:11804840 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:733704 6480464 3 more ... CTD PMID:35618242 3-phenylprop-2-enal multiple interactions ISO RGD:733704 6480464 edelfosine inhibits the reaction [F2RL1 protein promotes the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]], F2RL1 protein promotes the reaction [cinnamaldehyde results in increased activity of TRPA1 protein] CTD PMID:17571167 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of F2RL1 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol increases expression ISO RGD:1553673 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of F2RL1 mRNA CTD PMID:30951980 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:733704 6480464 Oxazolone results in increased expression of F2RL1 mRNA CTD PMID:23999411 4-hydroxyphenyl retinamide increases expression ISO RGD:1553673 6480464 Fenretinide results in increased expression of F2RL1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:733704 6480464 Decitabine affects the expression of F2RL1 mRNA CTD PMID:17145863 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of F2RL1 mRNA CTD PMID:30047161 aflatoxin B1 increases expression ISO RGD:733704 6480464 Aflatoxin B1 results in increased expression of F2RL1 mRNA CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:733704 6480464 Tretinoin results in increased expression of F2RL1 mRNA CTD PMID:21934132 allyl isothiocyanate multiple interactions ISO RGD:733704 6480464 edelfosine inhibits the reaction [F2RL1 protein promotes the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]] more ... CTD PMID:17571167 amitrole increases expression EXP 6480464 Amitrole results in increased expression of F2RL1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of F2RL1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:733704 6480464 Antirheumatic Agents results in decreased expression of F2RL1 mRNA CTD PMID:17696278 aripiprazole multiple interactions ISO RGD:733704 6480464 Aripiprazole inhibits the reaction [Ozone results in increased expression of F2RL1 mRNA] CTD PMID:31476115 arsenous acid increases expression ISO RGD:733704 6480464 Arsenic Trioxide results in increased expression of F2RL1 mRNA CTD PMID:25258189 arsenous acid decreases response to substance ISO RGD:733704 6480464 F2RL1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of F2RL1 mRNA CTD PMID:36841081 barium(0) multiple interactions ISO RGD:733704 6480464 Barium inhibits the reaction [F2RL1 protein results in increased transport of Chlorides], F2RL1 protein affects the reaction [1-oleoyl-2-acetoyl-sn-glycerol results in increased transport of Barium] CTD PMID:11804840 , PMID:16123040 belinostat decreases expression ISO RGD:733704 6480464 belinostat results in decreased expression of F2RL1 mRNA CTD PMID:27188386 belinostat increases expression ISO RGD:733704 6480464 belinostat results in increased expression of F2RL1 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:733704 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F2RL1 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:1553673 6480464 Benzo(a)pyrene results in decreased expression of F2RL1 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:733704 6480464 Benzo(a)pyrene results in decreased expression of F2RL1 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:733704 6480464 Benzo(a)pyrene affects the methylation of F2RL1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:733704 6480464 Benzo(a)pyrene results in increased expression of F2RL1 mRNA CTD PMID:21632981 , PMID:21871943 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of F2RL1 mRNA CTD PMID:15620428 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of F2RL1 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A increases expression ISO RGD:1553673 6480464 bisphenol A results in increased expression of F2RL1 mRNA CTD PMID:32156529 bisphenol A decreases expression ISO RGD:1553673 6480464 bisphenol A results in decreased expression of F2RL1 mRNA CTD PMID:35479511 bisphenol A multiple interactions ISO RGD:733704 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of F2RL1 gene CTD PMID:31601247 bisphenol A affects expression ISO RGD:733704 6480464 bisphenol A affects the expression of F2RL1 mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of F2RL1 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of F2RL1 gene CTD PMID:28505145 bisphenol F increases expression ISO RGD:1553673 6480464 bisphenol F results in increased expression of F2RL1 mRNA CTD PMID:30951980 bleomycin A2 multiple interactions EXP 6480464 allyl sulfide inhibits the reaction [Bleomycin results in increased expression of F2RL1 mRNA], allyl sulfide inhibits the reaction [Bleomycin results in increased expression of F2RL1 protein] CTD PMID:23656969 bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of F2RL1 mRNA, Bleomycin results in increased expression of F2RL1 protein CTD PMID:23656969 bortezomib decreases expression ISO RGD:733704 6480464 Bortezomib results in decreased expression of F2RL1 mRNA CTD PMID:20977926 bumetanide multiple interactions ISO RGD:733704 6480464 Bumetanide inhibits the reaction [F2RL1 protein results in increased transport of Chlorides] CTD PMID:11804840 butan-1-ol multiple interactions ISO RGD:733704 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of F2RL1 mRNA CTD PMID:29432896 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of F2RL1 mRNA CTD PMID:19167457 calcium atom multiple interactions ISO RGD:733704 6480464 F2RL1 protein promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased abundance of Calcium], PRKCE protein affects the reaction [F2RL1 protein promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased abundance of Calcium]] CTD PMID:16793902 calcium(0) multiple interactions ISO RGD:733704 6480464 F2RL1 protein promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased abundance of Calcium], PRKCE protein affects the reaction [F2RL1 protein promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased abundance of Calcium]] CTD PMID:16793902 capsaicin multiple interactions ISO RGD:733704 6480464 F2RL1 protein promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased abundance of Calcium], PRKCE protein affects the reaction [F2RL1 protein promotes the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased abundance of Calcium]] CTD PMID:16793902 carbamazepine affects expression ISO RGD:733704 6480464 Carbamazepine affects the expression of F2RL1 mRNA CTD PMID:25979313 chlorpyrifos increases expression ISO RGD:1553673 6480464 Chlorpyrifos results in increased expression of F2RL1 mRNA CTD PMID:37019170 cisplatin multiple interactions ISO RGD:733704 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of F2RL1 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:733704 6480464 Cisplatin results in decreased expression of F2RL1 mRNA CTD PMID:27392435 clotrimazole multiple interactions ISO RGD:733704 6480464 Clotrimazole inhibits the reaction [F2RL1 protein results in increased transport of Chlorides] CTD PMID:11804840 copper atom multiple interactions ISO RGD:733704 6480464 [NSC 689534 binds to Copper] which results in decreased expression of F2RL1 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:733704 6480464 [NSC 689534 binds to Copper] which results in decreased expression of F2RL1 mRNA CTD PMID:20971185 coumestrol multiple interactions ISO RGD:733704 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of F2RL1 mRNA CTD PMID:19167446 coumestrol decreases expression ISO RGD:733704 6480464 Coumestrol results in decreased expression of F2RL1 mRNA CTD PMID:19167446 crocidolite asbestos affects expression ISO RGD:733704 6480464 Asbestos, Crocidolite affects the expression of F2RL1 mRNA CTD PMID:25757056 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of F2RL1 protein CTD PMID:15643279 cyclosporin A decreases expression ISO RGD:733704 6480464 Cyclosporine results in decreased expression of F2RL1 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:733704 6480464 Cyclosporine results in increased expression of F2RL1 mRNA CTD PMID:21632981 , PMID:25562108 dextran sulfate multiple interactions ISO RGD:1553673 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of F2RL1 mRNA CTD PMID:29950665 Diallyl sulfide multiple interactions EXP 6480464 allyl sulfide inhibits the reaction [Bleomycin results in increased expression of F2RL1 mRNA], allyl sulfide inhibits the reaction [Bleomycin results in increased expression of F2RL1 protein] CTD PMID:23656969 diarsenic trioxide decreases response to substance ISO RGD:733704 6480464 F2RL1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diarsenic trioxide increases expression ISO RGD:733704 6480464 Arsenic Trioxide results in increased expression of F2RL1 mRNA CTD PMID:25258189 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of F2RL1 mRNA CTD PMID:15620428 dinophysistoxin 1 increases expression ISO RGD:733704 6480464 dinophysistoxin 1 results in increased expression of F2RL1 mRNA CTD PMID:28939011 dorsomorphin multiple interactions ISO RGD:733704 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:733704 6480464 Doxorubicin results in decreased expression of F2RL1 mRNA CTD PMID:29803840 edelfosine multiple interactions ISO RGD:733704 6480464 edelfosine inhibits the reaction [F2RL1 protein promotes the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]], edelfosine inhibits the reaction [F2RL1 protein promotes the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]] CTD PMID:17571167 Enterolactone multiple interactions ISO RGD:733704 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of F2RL1 mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:733704 6480464 entinostat results in increased expression of F2RL1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:733704 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F2RL1 mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:1553673 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of F2RL1 mRNA CTD PMID:30517762 ethanol multiple interactions ISO RGD:733704 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of F2RL1 mRNA CTD PMID:29432896 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of F2RL1 mRNA CTD PMID:30307764 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of F2RL1 mRNA CTD PMID:18035473 fulvestrant multiple interactions ISO RGD:733704 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of F2RL1 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of F2RL1 mRNA CTD PMID:27387713 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of F2RL1 mRNA CTD PMID:21782745 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of F2RL1 mRNA CTD PMID:33387578 graphite affects expression EXP 6480464 Graphite affects the expression of F2RL1 mRNA CTD PMID:29933104 hydrogen peroxide affects expression ISO RGD:733704 6480464 Hydrogen Peroxide affects the expression of F2RL1 mRNA CTD PMID:23410634 indometacin multiple interactions ISO RGD:733704 6480464 Indomethacin inhibits the reaction [F2RL1 protein results in increased transport of Chlorides] CTD PMID:11804840 isobutanol multiple interactions ISO RGD:733704 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of F2RL1 mRNA CTD PMID:29432896 leflunomide increases expression ISO RGD:733704 6480464 leflunomide results in increased expression of F2RL1 mRNA CTD PMID:28988120 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of F2RL1 protein CTD PMID:16300746 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of F2RL1 mRNA CTD PMID:28801915 menadione affects expression ISO RGD:733704 6480464 Vitamin K 3 affects the expression of F2RL1 mRNA CTD PMID:23410634 methimazole increases expression EXP 6480464 Methimazole results in increased expression of F2RL1 mRNA CTD PMID:30047161 methotrexate increases expression ISO RGD:733704 6480464 Methotrexate results in increased expression of F2RL1 mRNA CTD PMID:17400583 , PMID:17696278 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of F2RL1 mRNA CTD PMID:21782745 methylmercury chloride decreases expression ISO RGD:733704 6480464 methylmercuric chloride results in decreased expression of F2RL1 mRNA CTD PMID:23179753 methylparaben decreases expression ISO RGD:733704 6480464 methylparaben results in decreased expression of F2RL1 mRNA CTD PMID:31745603 N-nitrosodiethylamine increases expression ISO RGD:1553673 6480464 Diethylnitrosamine results in increased expression of F2RL1 mRNA CTD PMID:24535843 nickel atom decreases expression ISO RGD:733704 6480464 Nickel results in decreased expression of F2RL1 mRNA CTD PMID:23195993 nickel dichloride increases expression ISO RGD:733704 6480464 nickel chloride results in increased expression of F2RL1 mRNA CTD PMID:17312168 Nonylphenol decreases expression EXP 6480464 nonylphenol results in decreased expression of F2RL1 mRNA CTD PMID:15620428 ozone multiple interactions ISO RGD:733704 6480464 Aripiprazole inhibits the reaction [Ozone results in increased expression of F2RL1 mRNA] CTD PMID:31476115 ozone increases expression ISO RGD:733704 6480464 Ozone results in increased expression of F2RL1 mRNA CTD PMID:31476115 panobinostat multiple interactions ISO RGD:733704 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F2RL1 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:733704 6480464 panobinostat results in increased expression of F2RL1 mRNA CTD PMID:26272509 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of F2RL1 mRNA CTD PMID:33387578 paraquat increases expression EXP 6480464 Paraquat results in increased expression of F2RL1 mRNA CTD PMID:32680482 pentanal increases expression ISO RGD:733704 6480464 pentanal results in increased expression of F2RL1 mRNA CTD PMID:26079696 phenylmercury acetate multiple interactions ISO RGD:733704 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F2RL1 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:733704 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of F2RL1 mRNA CTD PMID:19710929 potassium chromate decreases expression ISO RGD:733704 6480464 potassium chromate(VI) results in decreased expression of F2RL1 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of F2RL1 mRNA CTD PMID:30047161 progesterone multiple interactions ISO RGD:733704 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of F2RL1 mRNA CTD PMID:20660070 quercetin increases expression ISO RGD:733704 6480464 Quercetin results in increased expression of F2RL1 mRNA CTD PMID:21632981 quercitrin increases expression ISO RGD:733704 6480464 quercitrin results in increased expression of F2RL1 mRNA CTD PMID:25193878 rac-lactic acid increases expression ISO RGD:733704 6480464 Lactic Acid results in increased expression of F2RL1 mRNA CTD PMID:30851411 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:733704 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of F2RL1 mRNA CTD PMID:33725128 SB 431542 multiple interactions ISO RGD:733704 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of F2RL1 mRNA CTD PMID:32721576 sodium arsenite decreases expression ISO RGD:733704 6480464 sodium arsenite results in decreased expression of F2RL1 mRNA CTD PMID:20371982 sotorasib multiple interactions ISO RGD:733704 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of F2RL1 mRNA CTD PMID:36139627 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of F2RL1 mRNA CTD PMID:30047161 Tanshinone I increases expression ISO RGD:733704 6480464 tanshinone results in increased expression of F2RL1 mRNA CTD PMID:15849732 temozolomide increases expression ISO RGD:733704 6480464 Temozolomide results in increased expression of F2RL1 mRNA CTD PMID:31758290 tert-butyl hydroperoxide affects expression ISO RGD:733704 6480464 tert-Butylhydroperoxide affects the expression of F2RL1 mRNA CTD PMID:23410634 tetrachloroethene increases expression ISO RGD:1553673 6480464 Tetrachloroethylene results in increased expression of F2RL1 mRNA CTD PMID:28973375 tetrachloromethane multiple interactions ISO RGD:1553673 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of F2RL1 mRNA CTD PMID:30517762 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of F2RL1 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of F2RL1 mRNA] CTD PMID:31150632 thapsigargin decreases expression ISO RGD:1553673 6480464 Thapsigargin results in decreased expression of F2RL1 protein CTD PMID:24648495 thapsigargin increases expression ISO RGD:733704 6480464 Thapsigargin results in increased expression of F2RL1 mRNA CTD PMID:29453283 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of F2RL1 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide multiple interactions ISO RGD:1553673 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of F2RL1 mRNA CTD PMID:29950665 trametinib multiple interactions ISO RGD:733704 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of F2RL1 mRNA CTD PMID:36139627 tributylstannane increases expression ISO RGD:1553673 6480464 tributyltin results in increased expression of F2RL1 mRNA CTD PMID:31939706 trichostatin A increases expression ISO RGD:733704 6480464 trichostatin A results in increased expression of F2RL1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:733704 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F2RL1 mRNA CTD PMID:27188386 triptonide increases expression ISO RGD:1553673 6480464 triptonide results in increased expression of F2RL1 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:733704 6480464 tris(2-butoxyethyl) phosphate affects the expression of F2RL1 mRNA CTD PMID:29024780 valproic acid decreases expression ISO RGD:1553673 6480464 Valproic Acid results in decreased expression of F2RL1 mRNA CTD PMID:21427059 valproic acid multiple interactions ISO RGD:733704 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F2RL1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:733704 6480464 Valproic Acid results in increased expression of F2RL1 mRNA CTD PMID:19101580 more ... vancomycin decreases expression ISO RGD:1553673 6480464 Vancomycin results in decreased expression of F2RL1 mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of F2RL1 mRNA CTD PMID:23034163 XL147 multiple interactions ISO RGD:1553673 6480464 XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of F2RL1 mRNA] CTD PMID:29891994
